glp 1 slow responder Some people lose far more weight than others on GLP-1s like Wegovy. Here's why I'm afraid I'm a non-responder

These preclinical findings support clinical trial results showing that tirzepatide, a dual GIPR/GLP-1R agonist, exhibits greater anti-obesity effects than GLP-1 receptor agonists alone

Read more on MIMS To view or add a comment, sign in About ATR-04, an investigational live biotherapeutic for EGFR inhibitor ("EGFRi") associated rash

As per a study , Unsaturated long-chain fatty acids have shown efficiency in stimulating GLP-1 production . So, do include a bit of healthy fats in your diet

Nearly 65% identify expanded coverage and affordability as the single most important factor shaping the future impact of GLP-1 therapy in obesity care